-
Posted by
Two Blokes Apr 18 -
Filed in
Stock
-
4 views
SAN FRANCISCO, April 18, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) reported its fourth-quarter 2024 earnings, missing analyst expectations and prompting a significant downward revision of its price target by at least one firm. The company is also facing a securities class action lawsuit alleging improper accounting.
